Physician profile
Zhipeng Yang
NPI 1821522962
$25,037.48
in general payments reported to CMS, 2019-2025
40 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.43 · 2021: $9,021 · 2022: $7,036 · 2023: $3,956 · 2024: $3,604 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,449 · Food and Beverage: $3,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,448.77 |
| Food and Beverage | $3,478.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $6,172.73 | 2021-2025 | |
| Paragon 28, INC. | $4,757.92 | 2021-2023 | Apex 3d, Monkey Bars |
| Stryker Corporation | $3,682.25 | 2021-2025 | Inbone, Hoffmann, Prostep Mica |
| Treace Medical Concepts, INC. | $2,631.48 | 2021-2025 | |
| Orthofix Medical, INC. | $1,933.72 | 2024 | Truelok, Truelok Evo, Tl-Hex Truelok Hexapod System |
| Medline Industries LP | $1,101.93 | 2023-2024 | |
| Medical Device Business Services, INC. | $1,025.53 | 2022 | |
| Arthrex, INC. | $902.80 | 2023-2025 | |
| Smith+Nephew, INC. | $480.05 | 2020-2025 | Q-Fix, Footprint, Collagenase Santyl |
| Organogenesis INC. | $437.54 | 2021-2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $302.88 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $190.57 | 2022-2024 | Fibergraft Aeridyan Matrix, Fibergraft Bg Morsels |
| Novastep INC. | $177.60 | 2022-2024 | Nexis, Peca Bunion Correction System |
| Biotissue Holdings INC. | $142.57 | 2023 | |
| Bioventus LLC | $125.42 | 2022-2025 | Theragenesis Bilayer Wound Matrix, Xcell, Exogen Ultrasound Bone Healing System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $109.21 | 2021 | |
| Trilliant Surgical LLC. | $80.65 | 2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Trice Medical, INC. | $69.56 | 2025 | |
| In2bones USA, LLC | $68.21 | 2021 | |
| Globus Medical, INC. | $67.93 | 2025 | Senza |
| Medshape, INC. | $59.99 | 2023 | Dynanail |
| Acumed LLC | $50.58 | 2025 | Acumed |
| Averitas Pharma INC. | $48.68 | 2023-2024 | Qutenza |
| Tactile Systems Technology INC | $45.75 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Acera Surgical, INC. | $44.76 | 2022 | |
| Abbvie INC. | $41.82 | 2022 | |
| Melinta Therapeutics, LLC | $30.30 | 2024-2025 | Kimyrsa, Orbactiv |
| Convatec INC. | $28.63 | 2023-2024 | |
| Nevro Corp. | $28.17 | 2023 | Senza |
| Polynovo North America LLC | $24.06 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.49 | 2025 | |
| Flower Orthopedics Coporation | $23.21 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.19 | 2024 | Tapestry, Genex |
| Aesculap, INC. | $21.35 | 2023 | Elan 4 |
| Pacira Pharmaceuticals Incorporated | $19.02 | 2022 | |
| Avanos Medical | $16.54 | 2021 | |
| Sanara Medtech INC. | $16.01 | 2024 | Celleraterx |
| Nabriva Therapeutics, Plc | $15.23 | 2021 | |
| Access Pro Medical, LLC | $14.34 | 2025 | Matriderm |
| Dynasplint Systems INC. | $2.81 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhipeng Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.